PERKUMPULANENDOKRINOLOGII N D O N E S I A

P E RK EN IP E R K EN IP E R K EN I

XIMalangEndocrinology Update Hotel Atria Malang

12 - 14 April 2019

Sekretariat: Divisi Endokrin Metabolik dan Diabetes, Departemen Ilmu Penyakit Dalam FK UB/ RSUD dr. Saiful Anwar,

Telp : 0341-351 445Jl. J.A. Suprapto 2 Malang E-mail : perkeni_mlg@yahoo.com | CP: Emerita 081233656805

Uang tidak kembali bila registrasi dibatalkann

Sertifikat hanya diberikan kepada peserta yang hadirn

............................................. , 2019

( .................................................. )

Pembayaran Tunai Transfer Bank Mandiri Capem RSCM NO. REK. 122-00-0760795-8 A/N PB PERKENI

n

Mohon diisi dan di email ke perkeni_mlg@yahoo.com

n Biaya Pendaftaran

Sampai dengan 20 Maret 2019

Setelah 20 Maret 2019Workshop

Simposium Internist

GP

Medical Student

Rp. 1.500.000,-

Rp. 1.000.000,-

Rp. 500.000,-

Rp. 1.000.000,-

Rp. 750.000,-

Rp. 300.000,-

Simposium + WorkshopSimposium + 1 Workshop GP Rp. 2.250.000,-

Rp. 2.750.000,-

Rp. 1.500.000,-

Rp. 1.750.000,-Simposium + 1 Workshop Internist

Rp. 1.500.000,-

Rp. 1.500.000,-

Rp. 1.000.000,-

Rp. 1.000.000,-

Clinical Workshop 1: Emergency in Endocrine diseases

Clinical Workshop 2:Diabetes in special cases

Simposium:Workshop:

Plenary Lecture:n Clinical decision making in endocrinologyn What is the guideline tell and not to tell us :

Summary of new ADA/EASD 2018 perspectiven Data mining to improve diabetes outcome :

Malang Diabetes Registry Projectn Clnicial inertia : Barrier to diabetes

management in primary care

n Perioperative management in Endocrine diseases

n Diabetes in special cases

n Screening tests for common endocrine diseasesn Pitfalls in Endocrine Testing and interpretation:

When What You See is not What You've Gotn Glucose-lowering therapies in older patients :

How to minimising the riskn Pharmacogenetic of type 2 diabetes :

Implication for clinical practicen Cardiovascular impact of glucose lowering

drugsn Diabetic Kidney Disease : What You need to

know ?n Newer Insulin in diabetes management : Do we

need it ?n Diabetes and Foot : What the recent guideline

sayn Exercise and type 2 diabetes : From metabolic

insight to clinical implicationn Choosing Evidence-Based Therapy for Type 2

Diabetes Mellitus with Cardiovascular Diseasen Insulin and cancer revisited : An endocrinologist

perspectiven Preventing Cardiovascular disease in diabetes :

Focus on Lipid and Blood Pressure

Pameran

Meet the Expert &Drug Positioning

Endo-diabetes 4.0 :Redefinisi “treat to target”pada kelainan dibidang endokrin